Literature DB >> 8259673

Analysis of interstrain variation in a putative immediate-early region of human herpesvirus 6 DNA and definition of variant-specific sequences.

S Chou1, G I Marousek.   

Abstract

Sequences of a 2.6- to 2.9-kb open reading frame in a putative immediate-early region of the human herpesvirus 6 (HHV6) genome were determined and compared in three reference and six local isolates of HHV6. The sequences segregated into two variant groups (A and B) having only 75% nucleotide homology and 62% peptide homology, in part because of deletions in the variant A strains. Among the variant B isolates, further sequence grouping was evident; two clinical isolates segregated with reference strain Z29 into a cluster that had 96.6% nucleotide homology and 92.6% peptide homology when compared to a second variant B cluster of four isolates. Within each cluster of variant B isolates, nucleotide homology was 99.4% or more. Two pairs of isolates had identical sequences. The marked divergence of variants A and B permitted the design of variant-specific oligonucleotide primers that could detect in a single polymerase chain reaction the presence of either or both variant A and B HHV6 DNA. Variation in this gene region of HHV6 is more extensive than in the envelope glycoprotein (gB and gH) coding regions and could be related to known biological differences between variant groups.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8259673     DOI: 10.1006/viro.1994.1044

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  12 in total

Review 1.  Human herpesvirus 6.

Authors:  D K Braun; G Dominguez; P E Pellett
Journal:  Clin Microbiol Rev       Date:  1997-07       Impact factor: 26.132

2.  Temporal mapping of transcripts in herpesvirus 6 variants.

Authors:  P Mirandola; P Menegazzi; S Merighi; T Ravaioli; E Cassai; D Di Luca
Journal:  J Virol       Date:  1998-05       Impact factor: 5.103

Review 3.  Update on human herpesvirus 6 biology, clinical features, and therapy.

Authors:  Leen De Bolle; Lieve Naesens; Erik De Clercq
Journal:  Clin Microbiol Rev       Date:  2005-01       Impact factor: 26.132

4.  Characterization of transcripts expressed from human herpesvirus 6A strain GS immediate-early region B U16-U17 open reading frames.

Authors:  L M Flebbe-Rehwaldt; C Wood; B Chandran
Journal:  J Virol       Date:  2000-12       Impact factor: 5.103

5.  Comparison of the complete DNA sequences of human herpesvirus 6 variants A and B.

Authors:  Y Isegawa; T Mukai; K Nakano; M Kagawa; J Chen; Y Mori; T Sunagawa; K Kawanishi; J Sashihara; A Hata; P Zou; H Kosuge; K Yamanishi
Journal:  J Virol       Date:  1999-10       Impact factor: 5.103

6.  Human herpesvirus 6B genome sequence: coding content and comparison with human herpesvirus 6A.

Authors:  G Dominguez; T R Dambaugh; F R Stamey; S Dewhurst; N Inoue; P E Pellett
Journal:  J Virol       Date:  1999-10       Impact factor: 5.103

7.  Coinfection with human herpesvirus 6 variants A and B in lung tissue.

Authors:  R W Cone; M L Huang; R C Hackman; L Corey
Journal:  J Clin Microbiol       Date:  1996-04       Impact factor: 5.948

8.  Identification of human herpesvirus 6 variants A and B by amplimer hybridization with variant-specific oligonucleotides and amplification with variant-specific primers.

Authors:  J T Aubin; L Poirel; C Robert; J M Huraux; H Agut
Journal:  J Clin Microbiol       Date:  1994-10       Impact factor: 5.948

9.  Restriction endonuclease mapping and molecular cloning of the human herpesvirus 6 variant B strain Z29 genome.

Authors:  G J Lindquester; N Inoue; R D Allen; J W Castelli; F R Stamey; T R Dambaugh; J J O'Brian; R M Danovich; N Frenkel; P E Pellett
Journal:  Arch Virol       Date:  1996       Impact factor: 2.574

10.  Plaque-associated expression of human herpesvirus 6 in multiple sclerosis.

Authors:  P B Challoner; K T Smith; J D Parker; D L MacLeod; S N Coulter; T M Rose; E R Schultz; J L Bennett; R L Garber; M Chang
Journal:  Proc Natl Acad Sci U S A       Date:  1995-08-01       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.